Skip to main content

Table 2 Characteristics of lesions

From: Prevalence of cutaneous leishmaniasis infection and clinico-epidemiological patterns among military personnel in Mullaitivu and Kilinochchi districts of the Northern Province, early war-torn areas in Sri Lanka

Lesion features

Response category

Percentage of respondents (n = 74)

Percentage of respondents (n = 74)

P-value

Positive for leishmaniasis

Negative for leishmaniasis

Number

1

86.5 (n = 64)

86.0 (n = 43)

87.6 (n = 21)

0.536

2

8.2 (n = 6)

10.0 (n = 5)

4.1 (n = 1)

> 2

5.4 (n = 4)

4.0 (n = 2)

8.3 (n = 2)

Site/s

Upper limb

66.2 (n = 49)

67.9 (n = 34)

62.6 (n = 15)

0.049

Lower limb

12.2 (n = 9)

6.1 (n = 3)

25.0 (n = 6)

Face

1.4 (n = 1)

2.0 (n = 1)

0 (n = 0)

Head

2.7 (n = 2)

4.0 (n = 2)

0 (n = 0)

Neck

5.4 (n = 4)

4.0 (n = 2)

8.3 (n = 2)

Chest

1.4 (n = 1)

0 (n = 0)

4.1 (n = 1)

Back

8.1 (n = 6)

12.0 (n = 6)

0 (n = 0)

Abdomen

2.7 (n = 2)

4.0 (n = 2)

0 (n = 0)

Type

Papule

28.4 (n = 21)

28.0 (n = 14)

29.1 (n = 7)

0.946

Nodule

33.8 (n = 25)

32.0 (n = 16)

37.6 (n = 9)

Plaque

5.5 (n = 4)

6.0 (n = 3)

4.1 (n = 1)

Ulcerated

32.5 (n = 24)

34.0 (n = 17)

29.2 (n = 7)

Size (mm)

< 5

5.5 (n = 4)

2.1 (n = 1)

12.5 (n = 3)

0.192

5–10

54 (n = 40)

59.9 (n = 30)

41.7 (n = 10)

11–30

37.8 (n = 28)

36.0 (n = 18)

41.7 (n = 10)

> 30

2.8 (n = 2)

2.0 (n = 1)

4.1 (n = 1)

Shape

Round

64.9 (n = 48)

66.0 (n = 33)

62.6 (n = 15)

0.950

Oval

31.1 (n = 23)

30.0 (n = 15)

33.3 (n = 8)

Irregular/other

4.1 (n = 3)

4.0 (n = 2)

4.1 (n = 1)

Margin is well defined

Yes

33.8 (n = 25)

28.0 (n = 14)

45.9 (n = 11)

0.048

No

66.2 (n = 49)

72.0 (n = 36)

54.1 (n = 13)

Edge of the lesion

Regular

31.1 (n = 23)

24.0 (n = 12)

45.9 (n = 11)

0.047

Irregular

69 (n = 51)

76.0 (n = 38)

54.1 (n = 13)

Consistency

Soft

4.1 (n = 3)

2.0 (n = 1)

8.4 (n = 2)

0.045

Firm

90.6 (n = 67)

92.0 (n = 46)

87.5 (n = 21)

Hard

5.5 (n = 4)

6.0 (n = 3)

4.1 (n = 1)

Scaling

Yes

44.6 (n = 33)

40.1 (n = 20)

54.3 (n = 13)

0.251

No

55.4 (n = 41)

59.9 (n = 30)

45.7 (n = 11)

Itching

Yes

21.7 (n = 16)

18.1 (n = 9)

29.1 (n = 7)

0.047

No

78.4 (n = 58)

81.9 (n = 41)

70.9 (n = 17)

Pain

Yes

6.8 (n = 5)

4.0 (n = 2)

12.6 (n = 3)

0.046

No

93.3 (n = 69)

96.0 (n = 48)

87.4 (n = 21)

Pus secretion

Yes

18.9 (n = 14)

16.0 (n = 8)

25.0 (n = 6)

0.049

No

81.1 (n = 60)

84.0 (n = 42)

75.0 (n = 18)

Presence of other discharge

Yes

25.7 (n = 19)

26.0 (n = 13)

25.0 (n = 6)

0.927

No

74.3 (n = 55)

74.0 (n = 37)

75.0 (n = 18)

Crusting

Yes

21.7 (n = 16)

22.0 (n = 11)

21.0 (n = 5)

0.771

No

78.4 (n = 58)

78.0 (n = 39)

79.0 (n = 19)

Skin changes

None

8.1 (n = 6)

4.0 (n = 2)

16.6 (n = 6)

0.241

Induration

37.8 (n = 28)

40.0 (n = 20)

33.3 (n = 8)

Erythema

35.2 (n = 26)

38.0 (n = 19)

29.9 (n = 7)

Hypopigmentation

10.8 (n = 8)

8.0 (n = 4)

16.6 (n = 4)

Hyperpigmentation

2.7 (n = 2)

4.0 (n = 2)

0 (n = 0)

Satellite lesion

2.7 (n = 2)

4.0 (n = 2)

0 (n = 0)

Subcutaneous nodules

2.7 (n = 2)

2.0 (n = 1)

4.1 (n = 1)

Scaling

0 (n = 0)

0 (n = 0)

0 (n = 0)

Vesicles

0 (n = 0)

0 (n = 0)

0 (n = 0)

  1. Notes: Suspected individuals with lesions who were confirmed to have leishmaniasis based on diagnostic tests were considered as “positive for leishmaniasis” (n = 50), while the rest were considered as “negative for leishmaniasis” (n = 24)